Outlook Therapeutics logo
Outlook Therapeutics OTLK
$ 6.08 0.25%

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Outlook Therapeutics Operating Cash Flow 2011-2024 | OTLK

Annual Operating Cash Flow Outlook Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-43 M -56.7 M -54.3 M -31.8 M -32.3 M -33 M -15.5 M - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-15.5 M -56.7 M -38.1 M

Quarterly Operating Cash Flow Outlook Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - -13 M - - - -8.9 M -46.4 M - - -11 M -45.3 M -25.1 M - -13.3 M -19.7 M -13.8 M -13.3 M -6.67 M -26.3 M -16 M -6.67 M -9.78 M -24.6 M -16.1 M -9.8 M -8.67 M -15.6 M - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-6.67 M -46.4 M -17.5 M